An expert shared their opinion on the growing concern that Mounjaro, which is a popular GLP-1 weight loss medication, is ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Mounjaro is a prescription injection, often used off-label for weight loss, that is administered under the skin to patients struggling with obesity and weight loss. Off-label means that the actual use ...

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

A decision is expected in the fourth quarter of 2025.

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...

"Ozempic feet" is a side effect of taking GLP-1 medications for weight loss. Here's why it happens and what you can do.